OptimizeRx Corporation (OPRX) SEC filings
OPRX SEC filings moved a median of -0.61% by the close. OPRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the OPRX overview →
57 measured OPRX SEC filing events.
Where these OPRX SEC filings landedvs 56 measured OPRX SEC filing reactions
| Middle 50% of OPRX SEC filing reactions | -4.23% to +1.72% |
|---|---|
| Median reaction (to close) | -0.61% |
| Measured reactions | 56 |
Point-in-time · zero look-ahead
Half of the 56 OPRX SEC filing events with a measured close landed between -4.23% and +1.72%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 OptimizeRx Corp | SEC filing · Form S-8 | +0.87% | -4.22% | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | +0.97% | +0.00% | |
| Form 8-K OptimizeRx Corp For: Aug 07 | SEC filing · Form 8-K | +8.50% | +28.74% | |
| Form 8-K OptimizeRx Corp For: Jun 09 | SEC filing · Form 8-K | +2.10% | +1.53% | |
| Form 8-K OptimizeRx Corp For: Jun 01 | SEC filing · Form 8-K | +0.19% | -1.94% | |
| Form DEFA14A OptimizeRx Corp | SEC filing · Form DEFA14A | +0.29% | +3.46% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | -0.79% | +2.37% | |
| Form 8-K OptimizeRx Corp For: May 12 | SEC filing · Form 8-K | -10.49% | -14.07% | |
| Form ARS OptimizeRx Corp For: Dec 31 | SEC filing · Form ARS | +0.41% | +0.81% | |
| Form DEF 14A OptimizeRx Corp For: Jun 09 | SEC filing · Form DEF | +0.41% | +0.81% | |
| Form 8-K OptimizeRx Corp For: Apr 03 | SEC filing · Form 8-K | -1.10% | -2.99% | |
| Form 8-K OptimizeRx Corp For: Mar 24 | SEC filing · Form 8-K | -0.69% | -3.68% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | +0.33% | +6.49% | |
| Form 8-K OptimizeRx Corp For: Mar 05 | SEC filing · Form 8-K | -13.83% | -2.88% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.37% | +2.48% | |
| Form 8-K OptimizeRx Corp For: Nov 06 | SEC filing · Form 8-K | -10.72% | -14.81% | |
| Form 8-K OptimizeRx Corp For: Aug 15 | SEC filing · Form 8-K | -1.03% | — | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | -6.57% | -6.47% | |
| Form 8-K OptimizeRx Corp For: Aug 07 | SEC filing · Form 8-K | +6.15% | +6.46% | |
| Form 8-K OptimizeRx Corp For: Jun 20 | SEC filing · Form 8-K | -0.12% | -0.62% | |
| Form 8-K OptimizeRx Corp For: Jun 11 | SEC filing · Form 8-K | -0.33% | -1.98% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | +4.25% | -8.51% | |
| Form 8-K OptimizeRx Corp For: May 12 | SEC filing · Form 8-K | +2.22% | -4.26% | |
| Form ARS OptimizeRx Corp For: Dec 31 | SEC filing · Form ARS | -1.84% | +1.67% | |
| Form DEF 14A OptimizeRx Corp For: Jun 11 | SEC filing · Form DEF | -1.84% | +1.67% | |
| Form 8-K OptimizeRx Corp For: Apr 18 | SEC filing · Form 8-K | +0.23% | -2.10% | |
| Form EFFECT OptimizeRx Corp | SEC filing · Form EFFECT | -3.27% | -9.93% | |
| Form S-3 OptimizeRx Corp | SEC filing · Form S-3 | -1.90% | +2.85% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | +0.70% | +0.82% | |
| Form 8-K OptimizeRx Corp For: Mar 12 | SEC filing · Form 8-K | +18.14% | +29.48% | |
| Form DEFA14A OptimizeRx Corp | SEC filing · Form DEFA14A | -2.35% | -2.59% | |
| Form 8-K OptimizeRx Corp For: Mar 10 | SEC filing · Form 8-K | +0.00% | -6.11% | |
| Form 8-K OptimizeRx Corp For: Jan 03 | SEC filing · Form 8-K | -1.71% | -7.79% | |
| Form 8-K OptimizeRx Corp For: Dec 19 | SEC filing · Form 8-K | -5.60% | +6.15% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.99% | +0.62% | |
| Form 8-K OptimizeRx Corp For: Nov 13 | SEC filing · Form 8-K | -3.74% | -14.53% | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | +0.95% | -0.60% | |
| Form NT 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form NT | -0.82% | -1.87% | |
| Form 8-K OptimizeRx Corp For: Aug 08 | SEC filing · Form 8-K | -0.28% | -5.20% | |
| Form S-8 POS OptimizeRx Corp | SEC filing · Form S-8 | +0.00% | +1.28% | |
| Form S-8 OptimizeRx Corp | SEC filing · Form S-8 | +0.00% | -0.28% | |
| Form 8-K OptimizeRx Corp For: Jun 05 | SEC filing · Form 8-K | +0.00% | +4.01% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -3.53% | |
| Form 8-K OptimizeRx Corp For: May 14 | SEC filing · Form 8-K | -4.95% | -5.59% | |
| Form 8-K OptimizeRx Corp For: Apr 26 | SEC filing · Form 8-K | +0.10% | +2.00% | |
| Form ARS OptimizeRx Corp For: Dec 31 | SEC filing · Form ARS | -0.10% | -1.48% | |
| Form DEF 14A OptimizeRx Corp For: Jun 05 | SEC filing · Form DEF | -0.10% | -1.48% | |
| Form 8-K OptimizeRx Corp For: Apr 16 | SEC filing · Form 8-K | +0.00% | +0.76% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | -0.45% | -9.62% | |
| Form 8-K OptimizeRx Corp For: Mar 28 | SEC filing · Form 8-K | -0.98% | +0.00% | |
| Form NT 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form NT | +3.90% | +3.14% | |
| Form 8-K OptimizeRx Corp For: Mar 11 | SEC filing · Form 8-K | -11.02% | -7.19% | |
| Form 8-K OptimizeRx Corp For: Jan 24 | SEC filing · Form 8-K | +0.00% | +1.88% | |
| Form 8-K/A OptimizeRx Corp For: Oct 20 | SEC filing · Form 8-K | -0.76% | +0.98% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.01% | |
| Form 8-K OptimizeRx Corp For: Nov 06 | SEC filing · Form 8-K | -8.93% | -10.76% | |
| Form 8-K OptimizeRx Corp For: Oct 20 | SEC filing · Form 8-K | +0.00% | -0.75% |
Keep exploring
More OPRX: earnings → · analyst actions → · OPRX overview →
Other Technology names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rogers Corporation (ROG) | 278 | -0.10% | 42% |
| SPS Commerce, Inc. (SPSC) | 277 | 0.00% | 50% |
| MITSUBISHI ELEC UNSP/ADR (MIELY) | 275 | 0.00% | 48% |
| Evertec, Inc. (EVTC) | 274 | -0.10% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.